OBGYN News

Physicians.....get the latest breaking news on OB/GYN. Free CME, accredited by the University of Pennsylvannia, is available for physicians and other medical professionals.

Nerve Block Shows Potential for Severe Menopausal Symptoms in Breast Cancer
HOFFMAN ESTATES, Ill. -- Breast cancer patients with intolerable menopause-like symptoms had dramatic relief following a stellate-ganglion block of nerves involved in temperature regulation, a pilot study here indicated.
Aprotinin (Trasylol) Down But Not Totally Out
ROCKVILLE, Md. -- The hemostasis drug aprotinin (Trasylol) will remain available to U.S. physicians under an investigational protocol, at least until the FDA sorts out the causes of excess deaths seen with the drug in a large randomized trial, the agency said.
In IVF, Viable Embryos Have Distinct Gene Pattern
VICTORIA, Australia -- Blastocysts that will go on to implant and develop into a baby have a distinct set of active genes that are turned off in those that are not viable, researchers said.
Longer Breastfeeding Linked to Lower RA Risk
MALMO, Sweden -- Women who breastfeed for an extended period of time after the birth of their children may be less likely to develop rheumatoid arthritis, researchers found.
FDA Approves Generics for Treatment of Restless Legs Syndrome
ROCKVILLE, Md. -- The FDA has given the go-ahead to four companies to produce generic versions of ropinirole hydrochloride (Requip) for treatment of moderate to severe restless legs syndrome.
FDA Okays Genetically Engineered Factor VIIa for Ambient Air Storage
ROCKVILLE, Md. -- The FDA has approved a new formulation of genetically engineered Factor VIIa, the clotting protein, that does not require refrigeration for storage.
Arthritis a Double Whammy for Patients with Diabetes
ATLANTA -- Not only is arthritis more common among diabetics, but those who have both conditions are less likely to get the exercise that's an important part of controlling diabetes.
AMA Backs FDA Pre-Screening of Direct-to-Consumer TV Drug Ads
WASHINGTON -- The American Medical Association, testifying before Congress, has endorsed the proposal that the FDA should review and approve all direct-to-consumer ads for new drugs before they are aired on television.

[ Back ]